Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2015
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543225/
http://dx.doi.org/10.1182/blood-2015-07-657387
_version_ 1782386586975993856
collection PubMed
description
format Online
Article
Text
id pubmed-4543225
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-45432252015-09-02 Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232. Blood Errata American Society of Hematology 2015-08-20 /pmc/articles/PMC4543225/ http://dx.doi.org/10.1182/blood-2015-07-657387 Text en © 2015 by The American Society of Hematology
spellingShingle Errata
Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
title Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
title_full Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
title_fullStr Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
title_full_unstemmed Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
title_short Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
title_sort cho b-s, zeng z, mu h, et al. antileukemia activity of the novel peptidic cxcr4 antagonist ly2510924 as monotherapy and in combination with chemotherapy. blood. 2015;126(2):222-232.
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543225/
http://dx.doi.org/10.1182/blood-2015-07-657387

Ejemplares similares